Global Preimplantation Genetics Diagnosis (PGD) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 91877
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Preimplantation Genetics Diagnosis (PGD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Preimplantation Genetics Diagnosis (PGD) size is estimated to be USD 113.9 million in 2026 from USD 99.8 million in 2020, with a change XX% between 2020 and 2021. The global Preimplantation Genetics Diagnosis (PGD) market size is expected to grow at a CAGR of 3.3% for the next five years.

Market segmentation

Preimplantation Genetics Diagnosis (PGD) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Gender Selection

Chromosomal Abnormalities

Single Gene Disorders

HLA Typing

Aneuploidy

X-Linked Diseases

Others

Market segment by Application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

Abbott Laboratories

Natera, Inc

PerkinElmer

Illumina

F. Hoffmann-La Roche

Thermo Fisher Scientific

Laboratory Corporation of America Holdings

Agilent Technologies

Quest Diagnostics Incorporated

Cooper Surgical

Beijing Genomics Institute (BGI)

Genea Limited

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Preimplantation Genetics Diagnosis (PGD) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Preimplantation Genetics Diagnosis (PGD), with revenue, gross margin and global market share of Preimplantation Genetics Diagnosis (PGD) from 2019 to 2021.

Chapter 3, the Preimplantation Genetics Diagnosis (PGD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Preimplantation Genetics Diagnosis (PGD) market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Preimplantation Genetics Diagnosis (PGD) research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Preimplantation Genetics Diagnosis (PGD)

1.2 Classification of Preimplantation Genetics Diagnosis (PGD) by Type

1.2.1 Overview: Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type in 2020

1.2.3 Gender Selection

1.2.4 Chromosomal Abnormalities

1.2.5 Single Gene Disorders

1.2.6 HLA Typing

1.2.7 Aneuploidy

1.2.8 X-Linked Diseases

1.2.9 Others

1.3 Global Preimplantation Genetics Diagnosis (PGD) Market by Application

1.3.1 Overview: Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Preimplantation Genetics Diagnosis (PGD) Market Size & Forecast

1.5 Global Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast by Region

1.5.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region, (2016-2021)

1.5.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2016-2026)

1.5.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2016-2026)

1.5.6 South America Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Preimplantation Genetics Diagnosis (PGD) Market Drivers

1.6.2 Preimplantation Genetics Diagnosis (PGD) Market Restraints

1.6.3 Preimplantation Genetics Diagnosis (PGD) Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.1.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Natera, Inc

2.2.1 Natera, Inc Details

2.2.2 Natera, Inc Major Business

2.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.2.4 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Natera, Inc Recent Developments and Future Plans

2.3 PerkinElmer

2.3.1 PerkinElmer Details

2.3.2 PerkinElmer Major Business

2.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.3.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 PerkinElmer Recent Developments and Future Plans

2.4 Illumina

2.4.1 Illumina Details

2.4.2 Illumina Major Business

2.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.4.4 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Illumina Recent Developments and Future Plans

2.5 F. Hoffmann-La Roche

2.5.1 F. Hoffmann-La Roche Details

2.5.2 F. Hoffmann-La Roche Major Business

2.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.5.4 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.6 Thermo Fisher Scientific

2.6.1 Thermo Fisher Scientific Details

2.6.2 Thermo Fisher Scientific Major Business

2.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.6.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.7 Laboratory Corporation of America Holdings

2.7.1 Laboratory Corporation of America Holdings Details

2.7.2 Laboratory Corporation of America Holdings Major Business

2.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.7.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans

2.8 Agilent Technologies

2.8.1 Agilent Technologies Details

2.8.2 Agilent Technologies Major Business

2.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.8.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Agilent Technologies Recent Developments and Future Plans

2.9 Quest Diagnostics Incorporated

2.9.1 Quest Diagnostics Incorporated Details

2.9.2 Quest Diagnostics Incorporated Major Business

2.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.9.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Quest Diagnostics Incorporated Recent Developments and Future Plans

2.10 Cooper Surgical

2.10.1 Cooper Surgical Details

2.10.2 Cooper Surgical Major Business

2.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.10.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Cooper Surgical Recent Developments and Future Plans

2.11 Beijing Genomics Institute (BGI)

2.11.1 Beijing Genomics Institute (BGI) Details

2.11.2 Beijing Genomics Institute (BGI) Major Business

2.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.11.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans

2.12 Genea Limited

2.12.1 Genea Limited Details

2.12.2 Genea Limited Major Business

2.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Product and Solutions

2.12.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Genea Limited Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Preimplantation Genetics Diagnosis (PGD) Players Market Share

3.2.2 Top 10 Preimplantation Genetics Diagnosis (PGD) Players Market Share

3.2.3 Market Competition Trend

3.3 Preimplantation Genetics Diagnosis (PGD) Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue and Market Share by Type (2016-2021)

4.2 Global Preimplantation Genetics Diagnosis (PGD) Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2016-2021)

5.2 Preimplantation Genetics Diagnosis (PGD) Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2026)

6.2 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2026)

6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country

6.3.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2026)

6.3.2 United States Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

6.3.3 Canada Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

6.3.4 Mexico Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2026)

7.2 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2026)

7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country

7.3.1 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2026)

7.3.2 Germany Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

7.3.3 France Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

7.3.5 Russia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

7.3.6 Italy Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2026)

8.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2026)

8.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region

8.3.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2016-2026)

8.3.2 China Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

8.3.3 Japan Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

8.3.4 South Korea Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

8.3.5 India Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

8.3.7 Australia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2026)

9.2 South America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2026)

9.3 South America Preimplantation Genetics Diagnosis (PGD) Market Size by Country

9.3.1 South America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2026)

9.3.2 Brazil Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

9.3.3 Argentina Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2026)

10.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2026)

10.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country

10.3.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2026)

10.3.2 Turkey Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

10.3.4 UAE Preimplantation Genetics Diagnosis (PGD) Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Preimplantation Genetics Diagnosis (PGD) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) by Region (2016-2021)

Table 5. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 9. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Natera, Inc Corporate Information, Head Office, and Major Competitors

Table 11. Natera, Inc Major Business

Table 12. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 13. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. PerkinElmer Corporate Information, Head Office, and Major Competitors

Table 15. PerkinElmer Major Business

Table 16. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 17. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Illumina Corporate Information, Head Office, and Major Competitors

Table 19. Illumina Major Business

Table 20. Illumina Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 21. Illumina Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 23. F. Hoffmann-La Roche Major Business

Table 24. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 25. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 27. Thermo Fisher Scientific Major Business

Table 28. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 29. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors

Table 31. Laboratory Corporation of America Holdings Major Business

Table 32. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 33. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 35. Agilent Technologies Major Business

Table 36. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 37. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Quest Diagnostics Incorporated Corporate Information, Head Office, and Major Competitors

Table 39. Quest Diagnostics Incorporated Major Business

Table 40. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 41. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Cooper Surgical Corporate Information, Head Office, and Major Competitors

Table 43. Cooper Surgical Major Business

Table 44. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 45. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Beijing Genomics Institute (BGI) Corporate Information, Head Office, and Major Competitors

Table 47. Beijing Genomics Institute (BGI) Major Business

Table 48. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 49. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Genea Limited Corporate Information, Head Office, and Major Competitors

Table 51. Genea Limited Major Business

Table 52. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product and Solutions

Table 53. Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) by Players (2019-2021)

Table 55. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Players (2019-2021)

Table 56. Breakdown of Preimplantation Genetics Diagnosis (PGD) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Preimplantation Genetics Diagnosis (PGD) Players Head Office, Products and Services Provided

Table 58. Preimplantation Genetics Diagnosis (PGD) Mergers & Acquisitions in the Past Five Years

Table 59. Preimplantation Genetics Diagnosis (PGD) New Entrants and Expansion Plans

Table 60. Global Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) by Type (2016-2021)

Table 61. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Type (2016-2021)

Table 62. Global Preimplantation Genetics Diagnosis (PGD) Revenue Forecast by Type (2021-2026)

Table 63. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2021)

Table 64. Global Preimplantation Genetics Diagnosis (PGD) Revenue Forecast by Application (2021-2026)

Table 65. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Preimplantation Genetics Diagnosis (PGD) Picture

Figure 2. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type in 2020

Figure 3. Gender Selection

Figure 4. Chromosomal Abnormalities

Figure 5. Single Gene Disorders

Figure 6. HLA Typing

Figure 7. Aneuploidy

Figure 8. X-Linked Diseases

Figure 9. Others

Figure 10. Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application in 2020

Figure 11. Hospitals Picture

Figure 12. Clinics Picture

Figure 13. Others Picture

Figure 14. Global Preimplantation Genetics Diagnosis (PGD) Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Preimplantation Genetics Diagnosis (PGD) Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region (2016-2026)

Figure 17. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region in 2020

Figure 18. North America Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Preimplantation Genetics Diagnosis (PGD) Market Drivers

Figure 24. Preimplantation Genetics Diagnosis (PGD) Market Restraints

Figure 25. Preimplantation Genetics Diagnosis (PGD) Market Trends

Figure 26. Abbott Laboratories Recent Developments and Future Plans

Figure 27. Natera, Inc Recent Developments and Future Plans

Figure 28. PerkinElmer Recent Developments and Future Plans

Figure 29. Illumina Recent Developments and Future Plans

Figure 30. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 31. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 32. Laboratory Corporation of America Holdings Recent Developments and Future Plans

Figure 33. Agilent Technologies Recent Developments and Future Plans

Figure 34. Quest Diagnostics Incorporated Recent Developments and Future Plans

Figure 35. Cooper Surgical Recent Developments and Future Plans

Figure 36. Beijing Genomics Institute (BGI) Recent Developments and Future Plans

Figure 37. Genea Limited Recent Developments and Future Plans

Figure 38. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Players in 2020

Figure 39. Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 40. Global Top 3 Players Preimplantation Genetics Diagnosis (PGD) Revenue Market Share in 2020

Figure 41. Global Top 10 Players Preimplantation Genetics Diagnosis (PGD) Revenue Market Share in 2020

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 43. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Type in 2020

Figure 44. Global Preimplantation Genetics Diagnosis (PGD) Market Share Forecast by Type (2021-2026)

Figure 45. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Application in 2020

Figure 46. Global Preimplantation Genetics Diagnosis (PGD) Market Share Forecast by Application (2021-2026)

Figure 47. North America Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type (2016-2026)

Figure 48. North America Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Application (2016-2026)

Figure 49. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Country (2016-2026)

Figure 50. United States Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Canada Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Mexico Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Europe Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type (2016-2026)

Figure 54. Europe Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Application (2016-2026)

Figure 55. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Country (2016-2026)

Figure 56. Germany Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. France Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. United Kingdom Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Russia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Italy Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type (2016-2026)

Figure 62. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Application (2016-2026)

Figure 63. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region (2016-2026)

Figure 64. China Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Japan Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South Korea Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. India Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Southeast Asia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Australia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South America Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type (2016-2026)

Figure 71. South America Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Application (2016-2026)

Figure 72. South America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Country (2016-2026)

Figure 73. Brazil Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Argentina Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type (2016-2026)

Figure 76. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Application (2016-2026)

Figure 77. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Country (2016-2026)

Figure 78. Turkey Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. UAE Preimplantation Genetics Diagnosis (PGD) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz